MA34261B1 - Comprime a delitage intestinal - Google Patents
Comprime a delitage intestinalInfo
- Publication number
- MA34261B1 MA34261B1 MA35410A MA35410A MA34261B1 MA 34261 B1 MA34261 B1 MA 34261B1 MA 35410 A MA35410 A MA 35410A MA 35410 A MA35410 A MA 35410A MA 34261 B1 MA34261 B1 MA 34261B1
- Authority
- MA
- Morocco
- Prior art keywords
- intestinal
- tablet
- deliting
- disrupt
- disinteds
- Prior art date
Links
- 230000000968 intestinal effect Effects 0.000 title abstract 4
- 210000000936 intestine Anatomy 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA PRÉSENTE INVENTION DIVULGUE UN COMPRIMÉ À DÉLITAGE INTESTINAL QUI EST CARACTÉRISÉ PAR LA RÉDUCTION DE LA QUANTITÉ DE TALC QUI Y EST UTILISÉE ET PAR L'ABSENCE DE COMPOSANT ALCALIN. LE COMPRIMÉ À DÉLITAGE INTESTINAL SE DÉSINTÈGRE RAPIDEMENT UNE FOIS DANS L'INTESTIN, DE SORTE QU'UN PRINCIPE ACTIF Y EST LIBÉRÉ. EN CONSÉQUENCE, LE COMPRIMÉ À DÉLITAGE INTESTINAL DISPOSE D'UNE BIODISPONIBILITÉ AMÉLIORÉE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010105666 | 2010-04-30 | ||
PCT/JP2011/060483 WO2011136376A1 (fr) | 2010-04-30 | 2011-04-28 | Comprimé à délitage intestinal |
Publications (1)
Publication Number | Publication Date |
---|---|
MA34261B1 true MA34261B1 (fr) | 2013-05-02 |
Family
ID=44861668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA35410A MA34261B1 (fr) | 2010-04-30 | 2011-04-28 | Comprime a delitage intestinal |
Country Status (19)
Country | Link |
---|---|
US (2) | US20130115292A1 (fr) |
EP (1) | EP2564838A4 (fr) |
JP (1) | JP5787882B2 (fr) |
KR (1) | KR101820181B1 (fr) |
CN (1) | CN102970982B (fr) |
BR (1) | BR112012027794A2 (fr) |
CA (1) | CA2797812C (fr) |
CL (1) | CL2012003028A1 (fr) |
CO (1) | CO6640256A2 (fr) |
CR (1) | CR20120582A (fr) |
DO (1) | DOP2012000278A (fr) |
EA (1) | EA030433B1 (fr) |
GT (1) | GT201200292A (fr) |
IL (1) | IL222754A (fr) |
MA (1) | MA34261B1 (fr) |
MY (1) | MY162392A (fr) |
SG (1) | SG185081A1 (fr) |
TN (1) | TN2012000507A1 (fr) |
WO (1) | WO2011136376A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10358404B2 (en) * | 2012-06-21 | 2019-07-23 | Covestro Llc | Process for the production of low molecular weight impact polyethers |
CN103349648B (zh) * | 2013-07-22 | 2015-03-25 | 南通广泰生化制品有限公司 | 枸橼酸他莫昔芬肠溶片 |
JP6448645B2 (ja) | 2013-12-20 | 2019-01-09 | ハー・ルンドベック・アクチエゼルスカベット | メランコリアの特徴を伴う抑うつ障害を処置するための、カッパ−活性を伴うオピオイド受容体拮抗薬およびボルチオキセチンの使用 |
CN104644594A (zh) * | 2015-02-03 | 2015-05-27 | 郑州大明药物科技有限公司 | 一种氢溴酸沃替西汀胃溶片及其制备方法 |
JO3456B1 (ar) | 2015-05-13 | 2020-07-05 | H Lundbeck As | فيروتيوكسيتين بيروجلوتامات |
EP3329921B1 (fr) | 2015-07-30 | 2024-03-27 | Takeda Pharmaceutical Company Limited | Comprimé |
WO2018065348A1 (fr) | 2016-10-05 | 2018-04-12 | Hexal Ag | Nouveau comprimé à enrobage entérique comprenant de la vortioxétine |
KR102026337B1 (ko) * | 2017-07-07 | 2019-09-27 | 영진약품 주식회사 | 1-[2-(2,4-디메틸페닐설파닐)페닐]피페라진의 신규염 및 이의 제조방법 |
CN112006995A (zh) * | 2020-08-14 | 2020-12-01 | 石药集团中奇制药技术(石家庄)有限公司 | 一种氢溴酸伏硫西汀片的制备方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4539198A (en) | 1983-07-07 | 1985-09-03 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
EP0520119A1 (fr) | 1991-06-17 | 1992-12-30 | Spirig Ag Pharmazeutische Präparate | Composition à base de diclofenac pour l'administration orale |
AU5310898A (en) | 1996-12-20 | 1998-07-17 | Dumex-Alpharma A/S | Release-controlled coated tablets |
WO2001058424A1 (fr) | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Composition flottante de liberation de medicament |
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
US20050025824A1 (en) | 2001-12-14 | 2005-02-03 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
US20040028737A1 (en) | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
WO2004108067A2 (fr) | 2003-04-03 | 2004-12-16 | Sun Pharmaceutical Industries Limited | Systeme de distribution de medicaments programme |
DE602004016316D1 (de) * | 2003-04-04 | 2008-10-16 | Lundbeck & Co As H | 4-(2-phenylsulfanyl-phenyl)-piperidin-derivate als serotonin-wiederaufnahme-hemmer |
WO2004096208A1 (fr) | 2003-04-25 | 2004-11-11 | Mitsubishi Pharma Corporation | Composition pour administration orale contenant un derive d'alkylene dioxybenzene |
RU2372893C2 (ru) | 2003-10-31 | 2009-11-20 | Хексал Аг | Содержащий фармацевтический агент состав с покрытием |
WO2005046648A1 (fr) | 2003-11-12 | 2005-05-26 | Glenmark Pharmaceuticals Ltd. | Formes pharmaceutiques a liberation prolongee contenant un agoniste alpha-2, tel que la tizanidine |
US20050244490A1 (en) | 2003-12-09 | 2005-11-03 | Michael Otto | Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy |
IL160095A0 (en) | 2004-01-28 | 2004-06-20 | Yissum Res Dev Co | Formulations for poorly soluble drugs |
KR100582350B1 (ko) | 2004-02-17 | 2006-05-22 | 한미약품 주식회사 | 탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제 |
EP1746975A2 (fr) | 2004-04-01 | 2007-01-31 | Teva Pharmaceutical Industries Limited | Formulations de 6-mercaptopurine a liberation retardee |
WO2005105036A1 (fr) | 2004-04-28 | 2005-11-10 | Natco Pharma Limited | Matrice muco-adhesive a liberation controlee contenant de la tolterodine, et procede d'elaboration |
RU2382637C2 (ru) | 2004-04-30 | 2010-02-27 | Астеллас Фарма Инк. | Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию |
AU2005269416B2 (en) | 2004-07-26 | 2011-07-28 | Teva Pharmaceutical Industries, Ltd. | Pharmaceutical dosage forms including rasagiline |
TW200626185A (en) * | 2004-12-17 | 2006-08-01 | Bpsi Holdings Inc | Enteric film coating composition containing entericpolymer micronized with detackifier |
US7745022B2 (en) * | 2005-07-22 | 2010-06-29 | Siemens Energy, Inc. | CMC with multiple matrix phases separated by diffusion barrier |
ES2379200T5 (es) * | 2006-06-16 | 2021-10-20 | H Lundbeck As | Bromhidrato de 1-[2-(2,4-Dimetilfenilsulfanil)fenil]piperazina como compuesto con recaptación de serotonina combinada con actividad 5-HT3 y 5-HT1A para el tratamiento del deterioro cognitivo |
TW200848411A (en) * | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
TWI405588B (zh) | 2007-03-20 | 2013-08-21 | Lundbeck & Co As H | 4-〔2-(4-甲苯基硫基)-苯基〕哌啶之鹽類的液體調配物 |
JP4630925B2 (ja) | 2008-10-28 | 2011-02-09 | 盛岡セイコー工業株式会社 | 収納トレー及び収納体 |
NZ598083A (en) * | 2009-08-24 | 2013-08-30 | Lundbeck & Co As H | New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine |
CA2797809A1 (fr) * | 2010-04-30 | 2011-11-03 | Takeda Pharmaceutical Company Limited | Comprime a delitage intestinal |
-
2011
- 2011-04-28 US US13/695,366 patent/US20130115292A1/en not_active Abandoned
- 2011-04-28 CA CA2797812A patent/CA2797812C/fr not_active Expired - Fee Related
- 2011-04-28 MA MA35410A patent/MA34261B1/fr unknown
- 2011-04-28 BR BR112012027794A patent/BR112012027794A2/pt not_active Application Discontinuation
- 2011-04-28 CN CN201180032293.6A patent/CN102970982B/zh active Active
- 2011-04-28 WO PCT/JP2011/060483 patent/WO2011136376A1/fr active Application Filing
- 2011-04-28 MY MYPI2012004782A patent/MY162392A/en unknown
- 2011-04-28 EA EA201291136A patent/EA030433B1/ru not_active IP Right Cessation
- 2011-04-28 EP EP11775157.8A patent/EP2564838A4/fr not_active Withdrawn
- 2011-04-28 JP JP2012512929A patent/JP5787882B2/ja not_active Expired - Fee Related
- 2011-04-28 SG SG2012079893A patent/SG185081A1/en unknown
- 2011-04-28 KR KR1020127031197A patent/KR101820181B1/ko active IP Right Grant
-
2012
- 2012-10-23 TN TNP2012000507A patent/TN2012000507A1/en unknown
- 2012-10-29 IL IL222754A patent/IL222754A/en active IP Right Grant
- 2012-10-29 CL CL2012003028A patent/CL2012003028A1/es unknown
- 2012-10-29 GT GT201200292A patent/GT201200292A/es unknown
- 2012-10-30 DO DO2012000278A patent/DOP2012000278A/es unknown
- 2012-11-15 CR CR20120582A patent/CR20120582A/es unknown
- 2012-11-29 CO CO12217154A patent/CO6640256A2/es not_active Application Discontinuation
-
2014
- 2014-12-26 US US14/583,441 patent/US20150110873A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2797812A1 (fr) | 2011-11-03 |
TN2012000507A1 (en) | 2014-04-01 |
EP2564838A1 (fr) | 2013-03-06 |
CL2012003028A1 (es) | 2013-03-01 |
DOP2012000278A (es) | 2012-12-15 |
CN102970982B (zh) | 2015-01-14 |
JP5787882B2 (ja) | 2015-09-30 |
IL222754A0 (en) | 2012-12-31 |
KR20130060221A (ko) | 2013-06-07 |
CO6640256A2 (es) | 2013-03-22 |
CN102970982A (zh) | 2013-03-13 |
WO2011136376A1 (fr) | 2011-11-03 |
GT201200292A (es) | 2015-03-09 |
CA2797812C (fr) | 2018-02-20 |
EP2564838A4 (fr) | 2014-06-04 |
EA030433B1 (ru) | 2018-08-31 |
KR101820181B1 (ko) | 2018-02-28 |
IL222754A (en) | 2017-09-28 |
JPWO2011136376A1 (ja) | 2013-07-22 |
SG185081A1 (en) | 2012-12-28 |
BR112012027794A2 (pt) | 2016-08-02 |
EA201291136A1 (ru) | 2013-04-30 |
MY162392A (en) | 2017-06-15 |
CR20120582A (es) | 2013-02-05 |
US20150110873A1 (en) | 2015-04-23 |
US20130115292A1 (en) | 2013-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA34261B1 (fr) | Comprime a delitage intestinal | |
MA41887A1 (fr) | Dérivé de glucagon et composition comprenant un conjugué à action prolongée de celui-ci | |
CL2016000838A1 (es) | Combinación farmacéutica que comprende un inhibidor específico de histona desacetilasa 6 (hdac6) derivado de pirimidin hidroxiamida y un inmunomodulador (imid); y su uso para el tratamiento de mieloma múltiple. | |
EP3018582A3 (fr) | Dispositif multiprocesseur | |
EA201690199A1 (ru) | Лекарственное средство для лечения неалкогольной жировой болезни печени | |
UY32116A (es) | Una formulación sólida de dosificación farmacéutica | |
EA201591907A1 (ru) | Ингибитор киназ | |
AR107529A1 (es) | Compuestos, composiciones y métodos para la estratificación de pacientes de cáncer y su tratamiento | |
EA201490688A1 (ru) | 2-тиопиримидиноны | |
CL2012002786A1 (es) | Comprimido sólido que se comprime directamente a partir del polvo que comprende meloxicam y uno o más exipientes; y un procedimiento de compresión directa. | |
EA201390814A1 (ru) | Перорально распадающаяся таблетка | |
CL2014002524A1 (es) | Composicion farmaceutica que comprende un compuesto activo de formula 1, antagonista de ccr3, dos diluyentes, un aglutinante, un desintegrante y un lubricante; formas de dosificacion en capsula, comprimido o comprimido recubierto con pelicula. | |
EA202091533A1 (ru) | Способы лечения диабета, гепатита и/или воспалительного заболевания печени | |
JP1638163S (ja) | 内視鏡用プロセッサ | |
MA38699A1 (fr) | Formulation orale pour le traitement de maladies cardiovasculaires | |
DK3807421T3 (da) | Fremgangsmåde til tidlig påvisning af et udbrud af nekrotisk enteritis i en fuglepopulation | |
ATE438381T1 (de) | Zolpidemtabletten | |
EA201691422A1 (ru) | Перорально распадающиеся таблетированные составы мемантина | |
MA51179A1 (fr) | Anticorps et fragments anti-vista | |
JP1771401S (ja) | 錠剤 | |
JP1771400S (ja) | 錠剤 | |
JP1771399S (ja) | 錠剤 | |
JP1771311S (ja) | 錠剤 | |
JP1770233S (ja) | 錠剤 | |
JP1723506S (ja) | 電子計算機用筐体 |